# Nigelle 5 in Prevention of Influanza

> **NCT04989101** · NA · COMPLETED · sponsor: **Hôpital Universitaire Sahloul** · enrollment: 500 (actual)

## Conditions studied

- COVID-19 Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Nigella

## Key facts

- **NCT ID:** NCT04989101
- **Lead sponsor:** Hôpital Universitaire Sahloul
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-05
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989101, "Nigelle 5 in Prevention of Influanza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04989101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*